InflaRx N.V. (IFRX)
USD 0.98
(6.05%)
USD 0.98
(6.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -37.03 Million | -33.74 Million | -39.93 Million | -36.52 Million | -43.2 Million | -23.71 Million |
| Net Income | -41.79 Million | -29.48 Million | -45.63 Million | -33.98 Million | -53.25 Million | -29.81 Million |
| Depreciation & Amortization | 556.14 Thousand | 596.59 Thousand | 669.43 Thousand | 712.71 Thousand | 663.16 Thousand | 174 Thousand |
| Deferred income taxes | -8.81 Million | - | 1.15 Million | 927.83 Thousand | 2.98 Million | -1.88 Million |
| Stock-based compensation | 3.41 Million | 6.04 Million | 4.33 Million | 1.11 Million | 6.83 Million | 12.08 Million |
| Change in working capital | 983.01 Thousand | -9.77 Million | 1.53 Million | -5.34 Million | 3.39 Million | 1.83 Million |
| Other non-cash items | 8.61 Million | -1.12 Million | -2 Million | 44.24 Thousand | -3.82 Million | -6.1 Million |
| Investing Cash Flow | -17.33 Million | 19.35 Million | -25.95 Million | 21.36 Million | 20.34 Million | -99.45 Million |
| Investments in PPE | -79.43 Thousand | -162.39 Thousand | -37.77 Thousand | -94.18 Thousand | -594.88 Thousand | -806 Thousand |
| Acquisitions | 17.61 Million | -19.52 Million | 37.77 Thousand | 94.18 Thousand | 594.88 Thousand | 806 Thousand |
| Investment purchases | -101.91 Million | -64.47 Million | -97.51 Million | -101.6 Million | -82.62 Million | -106.65 Million |
| Sales/Maturities of investments | 84.66 Million | 83.99 Million | 71.6 Million | 123.05 Million | 103.55 Million | 8.01 Million |
| Other Investing Activities | -17.61 Million | 19.52 Million | -37.77 Thousand | -94.18 Thousand | -594.88 Thousand | -808 Thousand |
| Financing Cash Flow | 52.98 Million | 1.93 Million | 61.57 Million | 9.17 Million | -294.34 Thousand | 49.64 Million |
| Debt repayment | -373.97 Thousand | -364.42 Thousand | -360.64 Thousand | -366.15 Thousand | -296.02 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 52.26 Million | 2.34 Million | 65.14 Million | 9.77 Million | 1671.15 | 53.44 Million |
| Other Financing Activities | 53.36 Million | -47.73 Thousand | -3.2 Million | -232.89 Thousand | 4.85 | -3.8 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 6.84 Million | -3.52 Million | 316.11 Thousand | -3.87 Million | 5.71 Million | 2.18 Million |
| Inventory | -11.13 Million | - | - | - | - | - |
| Other working capital | 5.27 Million | -6.25 Million | 1.22 Million | -1.47 Million | -2.32 Million | -356 Thousand |
| Cash at beginning of period | 16.21 Million | 26.24 Million | 25.96 Million | 33.13 Million | 55.38 Million | 123.28 Million |
| Cash at end of period | 12.77 Million | 16.26 Million | 26.24 Million | 25.96 Million | 33.13 Million | 55.38 Million |
| Capital Expenditure | -79.43 Thousand | -162.39 Thousand | -37.77 Thousand | -94.18 Thousand | -594.88 Thousand | -806 Thousand |
| Effect of forex changes on cash | -974.09 Thousand | 2.46 Million | 4.59 Million | -1.16 Million | 902.32 Thousand | 5.62 Million |
| Net cash flow / Change in cash | -3.44 Million | -9.98 Million | 281.31 Thousand | -7.16 Million | -22.25 Million | -67.89 Million |
| Free Cash Flow | -37.11 Million | -33.9 Million | -39.97 Million | -36.62 Million | -43.79 Million | -24.51 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.91 Million | -9.71 Million | -15.52 Million | -41.79 Million | -7.45 Million | -8.2 Million |
| Depreciation & Amortization | 139.68 Thousand | 124.67 Thousand | 132.05 Thousand | 556.14 Thousand | 138.92 Thousand | 145.35 Thousand |
| Deferred income taxes | - | - | -4.36 Million | -8.81 Million | 682.7 Thousand | 387.78 Thousand |
| Stock-based compensation | 1.21 Million | 1.86 Million | 452.99 Thousand | 3.41 Million | 722.09 Thousand | 1.03 Million |
| Change in working capital | 1.45 Million | -5.14 Million | 912.32 Thousand | 983.01 Thousand | 4.35 Million | -2.87 Million |
| Other non-cash items | -1.87 Million | 4.13 Million | 8.09 Million | 8.61 Million | -3.69 Million | -1.65 Million |
| Investing Cash Flow | 5.8 Million | 27.1 Million | 2.98 Million | -17.33 Million | 7.37 Million | -24.3 Million |
| Investments in PPE | -12.17 Thousand | -16.16 Thousand | -8428.58 | -79.43 Thousand | -21.26 Thousand | -18.62 Thousand |
| Acquisitions | - | - | - | 17.61 Million | 21.26 Thousand | 18.62 Thousand |
| Investment purchases | -19.75 Million | -3.58 Million | -11.11 Million | -101.91 Million | -8.51 Million | -57.95 Million |
| Sales/Maturities of investments | 25.57 Million | 30.7 Million | 14.12 Million | 84.66 Million | 15.91 Million | 33.66 Million |
| Other Investing Activities | 6 Million | 26.96 Million | -25.31 Thousand | -17.61 Million | -21.26 Thousand | -18.62 Thousand |
| Financing Cash Flow | -107.18 Thousand | -86.21 Thousand | -94.9 Thousand | 52.98 Million | -94.28 Thousand | 53.14 Million |
| Debt repayment | -107.34 Thousand | -85.7 Thousand | -94.9 Thousand | -373.97 Thousand | -94.28 Thousand | -91.04 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -600.3 Thousand | 52.26 Million | -25.45 Thousand | 53.12 Million |
| Other Financing Activities | - | - | 1.00 | 53.36 Million | -1.00 | 53.23 Million |
| Accounts receivables | 11.86 Thousand | -35.44 Thousand | 1.00 | - | -821.51 Thousand | -578.18 Thousand |
| Accounts payables | 977.81 Thousand | -4.39 Million | 5.81 Million | 6.84 Million | 821.51 Thousand | 578.18 Thousand |
| Inventory | 1.4 Million | 321.04 Thousand | -9.46 Million | -11.13 Million | -1.06 Million | -578.7 Thousand |
| Other working capital | -941.94 Thousand | -1.04 Million | 4.56 Million | 5.27 Million | 5.41 Million | -2.3 Million |
| Cash at beginning of period | 25.12 Million | 12.77 Million | 21.72 Million | 16.21 Million | 19.51 Million | 2.09 Million |
| Cash at end of period | 19.16 Million | 25.12 Million | 12.77 Million | 12.77 Million | 21.69 Million | 19.51 Million |
| Capital Expenditure | -12.17 Thousand | -16.16 Thousand | -8428.58 | -79.43 Thousand | -21.26 Thousand | -18.62 Thousand |
| Effect of forex changes on cash | 296.72 Thousand | 344.38 Thousand | -783.41 Thousand | -974.09 Thousand | 155.17 Thousand | -250.04 Thousand |
| Net cash flow / Change in cash | -5.96 Million | 12.34 Million | -8.95 Million | -3.44 Million | 2.17 Million | 17.41 Million |
| Free Cash Flow | -12.08 Million | -14.97 Million | -10.3 Million | -37.11 Million | -5.27 Million | -11.18 Million |
300052
BDN
LOT
0239
688357
300443